Genmab — Januar 2021
-
thx EL - nice looking ORR and counting stable disease very impressive indeed
-
"Sabari was confident enough in amivantamab’s data to take a swipe at mobocertinib, saying the Takeda program matched up poorly on safety given Thursday’s results" https://endpts.com/jj-pushes-new-amivantamab-data-for-nsclc-subset-trying-to-bolster-case-for-quick-fda-approval/
-
comments from Joshua Bauml, MD
@Jbauml -
have you guys been drinking again
-
by the way, that fierce biotech article said 'Though J&J may snag the first approval for this patient population, its drug is given through intravenous infusion, which could give mobocertinib, an oral drug, an advantage on the convenience side.' But we know Amivantamab is being tried in Subcutaneous form as well
-
we can only hope people are catching up to the fact, that it is a grant of warrants and not an exercise.
-
@E L 09:17, Seems like people finally understand that ownership in the company by the employees far outweigh the “negative” consequence of the increase in number of shares outstanding for the private investor. Took quite some time, but better late than never lol.
-
Det hjælper også betydeligt på investors forståelse, at warrents og kursstigninger understøtter begge interessenter. Hvis man kun ser warrents udstedelse, men kurstigninger halter, kan det godt give en lidt sur mavefornemmelse for enkelte aktieindehaver, som dermed oplever at store lønninger afregnes via kursfald fremfor selskabets alm driftsoverskud.
-
En virksomhed skal hele tiden gøre det attraktivt at være medarbejder, både i arbejdsforhold og aflønning, det gælder ikke mindst de dygtigste forskere, der er sikkert rift om dem, og så længe Genmab forgylder sine aktionærer så er hver en krone dem vel undt herfra.
-
Helt og aldeles enig. Der til sagt, uden kapital og investorerne ville der ikke være et vellønnet arbejdet. Så det er en sluttet cirkel, hvor det hele skal hænge sammen. Ellers fungerer den frie markedsøkonomien ikke
-
Jeg tror også, at når de sure opstød bliver sjældnere og sjældnere, hænger det sammen med den gode stigning i aktiekursen sidste år. De sure miner sås mest i nedturstiden, da det var et irritationsmoment flere gange om året at skulle æde yderligere nedgange forårsaget af salg af realiserede warrants.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind